Alpha Tau Medical (DRTS) EBT (2021 - 2026)
Alpha Tau Medical's (DRTS) quarterly EBT came in at $23.0 million in Q1 2026, up 167.11% year-on-year from $8.6 million in Q1 2025, and up 88.56% quarter-over-quarter from $12.2 million in Q4 2025.
Alpha Tau Medical (DRTS) EBT (2021 - 2026) Analysis & Trends
Alpha Tau Medical has disclosed EBT across 6 years of filings, most recently posting $23.0 million for Q1 2026.
- EBT for Q1 2026 came in at $23.0 million, up 167.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.9 million (up 75.74% YoY), and the FY2025 annual result was $42.5 million, up 33.9% from the prior year.
- EBT came in at $23.0 million for Q1 2026 at Alpha Tau Medical, up from $12.2 million in the prior quarter.
- In the past five years, EBT ranged from a high of $25.7 million in Q1 2022 to a low of $2.0 million in Q2 2022.
- The 5-year median for EBT is $8.2 million (2023), against an average of $9.4 million.
- Across the five-year window, EBT sank 71.39% in 2022 and soared 334.87% in 2023, its largest moves.
- Alpha Tau Medical's EBT stood at $3.4 million in 2022, then jumped by 116.83% to $7.4 million in 2023, then climbed by 28.78% to $9.5 million in 2024, then climbed by 28.47% to $12.2 million in 2025, then jumped by 88.56% to $23.0 million in 2026.
- The last three EBT figures came in at $23.0 million (Q1 2026), $12.2 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.48 Mn |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | 22.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.95 Mn |
| Dec 31, 2025 | 12.17 Mn |
| Sep 30, 2025 | 11.69 Mn |
| Jun 30, 2025 | 10.05 Mn |
| Mar 31, 2025 | 8.59 Mn |
| Dec 31, 2024 | 9.47 Mn |
| Sep 30, 2024 | 6.92 Mn |
| Jun 30, 2024 | 7.37 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Dec 31, 2023 | 7.36 Mn |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | 8.67 Mn |
| Mar 31, 2023 | 8.17 Mn |
| Dec 31, 2022 | 3.39 Mn |
| Sep 30, 2022 | 2.61 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 25.74 Mn |
| Dec 31, 2021 | 3.80 Mn |
| Sep 30, 2021 | 4.80 Mn |
| Jun 30, 2021 | 6.97 Mn |